FDA trims use of contentious Alzheimer's drug amid backlash
WASHINGTON (AP) — A month after approving a controversial new Alzheimer’s drug, U.S. health regulators on Thursday signed off on new prescribing instructions that are likely to limit its use. The Food and Drug Administration said th...



